RecruitingNot ApplicableNCT06158971
Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation
Sponsor
phenoMapper, LLC
Enrollment
10 participants
Start Date
Mar 12, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluation of safety and technical feasibility of the phenoWave MW Ablation System for microwave ablation of lesions in the lung.
Eligibility
Min Age: 45 YearsMax Age: 77 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether microwave ablation — a minimally invasive procedure that uses heat generated by microwave energy to destroy cancer tissue — is a safe and effective alternative to surgical removal for lung cancer and lung metastases. This is a feasibility study, meaning the focus is on whether the procedure can be done safely.
**You may be eligible if...**
- You are between 45 and 77 years old
- You have non-small cell lung cancer (NSCLC) or a solitary lung tumor that has spread from another cancer (metastasis), confirmed by biopsy
- You are eligible for surgical lung removal (lobectomy)
**You may NOT be eligible if...**
- You are outside the age range of 45 to 77
- You are not eligible for curative lung surgery
- You have multiple lung metastases
- Your biopsy has not confirmed lung cancer or metastasis
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEFlexible Bronchoscopic Microwave Ablation
The phenoWave flexible microwave ablation system will be used to perform soft tissue ablation in the lungs under image guidance.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06158971
Related Trials
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
NCT076326641 location
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
NCT0678009840 locations
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
NCT061596601 location
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
NCT036550151 location
Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules
NCT066383985 locations